Uncategorized
VIDEO: Allegro updates phase 2 studies on Luminate for DME
NEW ORLEANS ― At the Ophthalmology Innovation Summit here, Vicken Karageozian, MD, president of Allegro Ophthalmics, updates the phase 2 study progress for Luminate for the treatment of diabetic macular edema and the advancement to phase 3 trials.